Checkpoint Therapeutics, Inc. — Form D
Checkpoint Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-09-13. The offering totals $62.5M, of which $57.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-09-13
- Form: D
- Accession: 0001578563-16-000018
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $62.5M
- Amount sold: $57.8M
- Remaining: $4.7M
- Investors: 559
- Date of first sale: 2015-09-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-270499
Issuer
- Name: Checkpoint Therapeutics, Inc.
- CIK: 0001651407
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 95 SAWYER ROAD, WALTHAM, MA, 02453
- Phone: 781-652-4500
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Neil A Herskowitz | Director | WORCESTER, MA |
| Barry A Salzman | Director | New York, NY |
| Michael S Weiss | Director | New York, NY |
| DAVID J HORIN | Executive Officer | NEW YORK, NY |
| Barry F Salzman | Director | Waltham, MA |
| Michael F Weiss | Director | Waltham, MA |
| Amit A Sharma | Director | Waltham, MA |
| Neil F Herskowitz | Director | Waltham, MA |
| Christian F Bechon | Director | Waltham, MA |
| James F Oliviero, III | Director | Waltham, MA |
| James F Oliviero, III | Executive Officer | Waltham, MA |
| Garrett F Gray | Executive Officer | Waltham, MA |
| Scott A Boilen | Director | Waltham, MA |
| Lindsay A Rosenwald | Director | New York, NY |
Other filings by this issuer (4)
More